Elsevier

Regulatory Peptides

Volume 65, Issue 1, 27 August 1996, Pages 91-97
Regulatory Peptides

Regular paper
JMV641: A potent bombesin receptor antagonist that inhibits Swiss 3T3 cell proliferation

https://doi.org/10.1016/0167-0115(96)00077-8Get rights and content

Abstract

The peptides of the bombesin family are involved in stimulation of mitogenesis in various cell lines, including cancerous cell lines. Bombesin receptor antagonists are of great interest to inhibit this proliferation. We have synthesized a potent bombesin receptor antagonist, e.g., compound JMV641 [H-dPhe-Gln-Trp-Ala-Val-Gly-His-NH-∗CH[CH2-CH(CH3)2]-∗ ∗CHOH-(CH2)3-CH3 [∗(S); ∗ ∗92% of (S) isomer], in which a pseudopeptide bond mimicking the transition state analogue replaced the peptide bond between the two C-terminal residues. This compound was highly potent to dose-dependently inhibit binding of 125I-GRP to Swiss 3T3 cells (IC50 = 0.85 ± 0.15 nM) and bombesin-stimulated Swiss 3T3 proliferation (pA2 = 8.78). However, compound JMV641 can inhibit bombesin-induced AP-1 regulated genes that are nuclear messengers mediating the actions of signal transduction pathways stimulated by growth factors.

References (24)

  • J. Martinez et al.

    Phenethyl ester derivative analogues of the C-terminal tetrapeptide of gastrin as potent gastrin antagonists

    J. Med. Chem.

    (1986)
  • J. Martinez et al.

    Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: On the importance of the peptide backbone

    J. Med. Chem.

    (1985)
  • Cited by (0)

    View full text